Indoco Remedies Limited

Indoco Remedies Limited Share · INE873D01024 (XBOM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Indoco Remedies Limited
No Price
Closing Price XBOM 30.04.2026: 209,05 INR
30.04.2026 09:59
Current Prices from Indoco Remedies Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
INDOCO.NS
INR
30.04.2026 09:59
209,10 INR
-
XBOM: MSE
MSE
INDOCO.BO
INR
30.04.2026 09:57
209,05 INR
-
Share Float & Liquidity
Free Float 39,35 %
Shares Float 36,26 M
Shares Outstanding 92,16 M
Company Profile for Indoco Remedies Limited Share
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Company Data

Name Indoco Remedies Limited
Company Indoco Remedies Limited
Website https://www.indoco.com
Primary Exchange XBOM MSE
ISIN INE873D01024
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Suresh Govind Kare
Market Capitalization 19 Mrd.
Country India
Currency INR
Employees 6,0 T
Address Indoco House, 400098 Mumbai
IPO Date 2005-01-14
Dividends from 'Indoco Remedies Limited'
Ex-Date Dividend per Share
04.09.2025 0,20 INR
19.09.2024 1,50 INR
18.09.2023 2,25 INR
14.09.2022 2,25 INR
17.09.2021 1,50 INR
18.09.2020 0,30 INR
22.08.2019 0,30 INR
31.08.2018 1,00 INR
31.07.2017 1,60 INR
20.07.2016 0,20 INR

Stock Splits

Date Split
17.05.2012 15:2

Ticker Symbols

Name Symbol
MSE INDOCO.BO
NSE INDOCO.NS
More Shares
Investors who hold Indoco Remedies Limited also have the following shares in their portfolio:
ATHERSYS INC
ATHERSYS INC Share
Brown Advisory Global Leaders Fund - Investor
Brown Advisory Global Leaders Fund - Investor Fund